Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Thymogen and Thymulin Interaction: Compatible | Peptide Database

Compound Profiles Thymogen EW Dipeptide | Thymus Immune Bioregulator Thymogen works through multiple immunomodulatory mechanisms: (1) activates T-cell differentiation and T-cell recognition of peptide-MHC complexes, (2) induces changes in intracellular cyclic

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Compound Profiles

Thymogen

EW Dipeptide | Thymus Immune Bioregulator

Thymogen works through multiple immunomodulatory mechanisms: (1) activates T-cell differentiation and T-cell recognition of peptide-MHC complexes, (2) induces changes in intracellular cyclic nucleotide composition, (3) activates neutrophilic chemotaxis and phagocytosis, (4) normalizes T-lymphocyte concentrations and ratios (CD3+, CD4+, CD8+), (5) stimulates production of immunoglobulins (IgA, IgG, IgE, IgM), and (6) enhances lymphocyte differentiation receptor expression. Research suggests Thymogen may interact specifically with the AACG DNA sequence, affecting gene expression.

Thymulin

FTS | Zinc-Dependent Thymic Nonapeptide

Thymulin exerts its effects through binding to high-affinity receptors on T-lymphocytes and other immune cells. The zinc-thymulin complex is the biologically active form - without zinc, the peptide has no immunological activity.

Shared Safety Flags

Frequently Asked Questions

Can I take Thymogen with Thymulin?

Yes, Thymogen and Thymulin can generally be taken together. Different structures and mechanisms; can be used together.

Is Thymogen and Thymulin safe together?

Based on documented research, this combination is considered compatible. However, shared safety flags include: teratogenic. Monitor accordingly.

What are the interactions between Thymogen and Thymulin?

Different structures and mechanisms; can be used together. This assessment has 90% confidence and is based on documented research data.

How should I time Thymogen and Thymulin?

Thymogen has a half-life of Not established and Thymulin has a half-life of ~10 minutes (free form); extended with nanoparticle formulations. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

Why is TB-500 dosed 2.5x higher in Tri-Heal Max versus standard Wolverine Stack?

Tri-Heal Max emphasizes TB-500's superior cell migration and angiogenesis properties (25mg vs standard 10mg) for more significant tissue damage. The 2.5:1 ratio targets acute injuries, majo…

Source: peptide-db.com
comparison

What's the ideal 5/5 vs 10/3 ratio for Tesa/IPA and when to use each?

5/5 (equal parts) provides balanced GH stimulation suitable for general recovery. The 10/3 (higher tesamorelin) variant emphasizes visceral fat loss and metabolic effects. Choose 5/5 for at…

Source: peptide-db.com
comparison

BPC-157 vs TB-500: Mechanisms, Dosing & the Wolverine Stack

How BPC-157 and TB-500 compare for healing: mechanism differences, dosing protocols, clinical evidence, and when to combine both in the Wolverine Stack.

Source: peptide-db.com
Research context

Read sources and limitations before applying a claim.

Community Research

Join others researching NA-Selank Amidate — share findings, ask questions, and learn from real experiences NA-Selank Amidate is an enhanced version of Selank, the anxiolytic nootropic peptide developed at Russia's Institute of Molecular Genetics. The N-acetyl group improves blood-brain barrier penetration and creates more stable metabolites, while the C-terminal amidation further enhances metabolic stability and receptor binding. Unlike benzodiazepines, it provides anxiety relief without sedation, dependency, or cognitive impairment. NA-Selank Amidate modulates multiple neurotransmitter systems including GABA, dopamine, and serotonin, while regulating brain-derived neurotrophic factor (BDNF). It allosterically modulates GABAA receptors without causing the sedation or dependency of benzodiazepines. The peptide activates serotonin metabolism in the hypothalamus and brainstem, and increases BDNF levels to promote neuronal growth and differentiation.

Source: peptide-db.com ↗

Research Indications

ATTAIN-1 demonstrated 12.4% weight loss (27.3 lbs) at 72 weeks with 36mg dose; 59.6% achieving ≥10% weight loss. ATTAIN-2 showed 10.5% weight loss with 72.8% achieving ≥5% weight loss. Improvements in waist circumference, systolic blood pressure (8-12 mmHg), triglycerides (-20-30%). 91% achieved near-normal blood sugar levels versus 42% with placebo. ACHIEVE-1 Phase 3 trial showed HbA1c reductions of 1.3-1.6% from 8.0% baseline; 76.2% achieving HbA1c <7%. Significant improvements in insulin sensitivity indices within 4 weeks of therapy initiation.

Source: peptide-db.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Dosing Protocols

Anastrozole is administered orally as a tablet. It is well absorbed with approximately 83-85% bioavailability, and absorption is not significantly affected by food. The long half-life of 40-50 hours supports dosing every other day or every three days for most estrogen management protocols, rather than daily dosing which is primarily reserved for the medical breast cancer indication. On-cycle estrogen management (conservative) 0.25mg Every other day (EOD) or every 3 days (E3D) Oral On-cycle estrogen management (moderate) 0.5mg On-cycle estrogen management (aggressive) 1mg Every other day (EOD) TRT adjunct (low-dose) 0.125-0.25mg Twice weekly or as needed based on bloodwork Breast cancer treatment (medical) Once daily

Source: peptide-db.com ↗
Side effects

Common Side Effects

Injection site reactions (redness, mild irritation) Potential transient hypotension due to vasodilatory effects

Source: peptide-db.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →

Continue learning

Related guides

01
Peptide Therapy Guide Editorial Team

VIP Overview, Dosing & Safety | Peptide Database

VIP (Vasoactive Intestinal Polypeptide) Vasoactive Intestinal Peptide | Neuropeptide Community Research Join others researching VIP — share findings, ask questions, and learn from real experiences Vasoactive I…

Read guide →
03
Peptide Therapy Guide Editorial Team

Vilon Overview, Dosing & Safety | Peptide Database

Vilon (KE) KE Dipeptide | Thymus Immune Bioregulator Community Research Join others researching Vilon — share findings, ask questions, and learn from real experiences Vilon is a Khavinson bioregulator dipeptid…

Read guide →